Vandetanib as a prospective anti-inflammatory and anti-contractile agent in asthma
Article in Frontiers in Pharmacology (May 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
PP121, a dual inhibitor of tyrosine and phosphoinositide kinases, relieves airway hyperresponsiveness, mucus hypersecretion and inflammation in a murine asthma model
Article in Molecular Medicine (November 2023)
Lycium barbarum polysaccharides improve gut microbiota composition and alleviate pulmonary inflammatory damage in allergic asthma mice by inhibiting the IL-15RA/FUT2 pathway
Article in Journal of Functional Foods (September 2023)